INJECTION INDEXWeight management, clearly.
The online care edition
October 2026
Offer profile · October 1, 2026

PlushCare Review

PlushCare’s $129 self-pay initial visit is a consultation price; membership, medicines and laboratory costs are separate parts of the comparison.

PlushCare describes online weight care from primary care physicians, with prescription medication when medically appropriate. Its offer is fundamentally visit-centered. The advertised $129 initial self-pay visit does not purchase a complete month of medication, and the public pricing description makes that separation explicit.

The service can be used with or without insurance and describes continuing monitoring. Those are useful access features. Understanding them requires keeping membership, visits, prescription costs and any laboratory work apart rather than compressing everything into the smallest price on the page.

The self-pay price has a limited scope

The reviewed pricing section lists $129 for an initial visit without insurance. It also lists membership at $19.99 with the first month free. Medication and laboratory costs are explicitly excluded from the visit amount. A consultation quote therefore cannot be compared directly with a provider’s medication-inclusive package. The free membership month does not erase the separate visit charge.

For insured visits, the page describes a copay arrangement. That is not an individual coverage determination. The complete amount depends on the visit, current membership terms, prescribed medicine and any additional services. The cost guide helps separate those components without predicting a personal insurance benefit.

A primary care assessment can lead to different plans

PlushCare says doctors may order necessary evaluations or laboratory tests before choosing a treatment route. It lists medicines in separate weight-loss and type-2-diabetes categories. That distinction matters: an available discussion is not proof that every medicine has the same approved purpose or will be prescribed.

The record also says a treatment plan may or may not include medication. A reader paying for a visit is purchasing access to an assessment, rather than a guaranteed preferred prescription. No eligibility assessment or clinician sign-off was obtained for this editorial review.

Ongoing care and membership are related, but distinct

The membership description includes care-team messages, appointment access and laboratory discounts. The clinical description separately says the physician monitors progress, including after a goal is reached. These are advertised service components, not response times or long-term outcomes observed here.

The difference is practical. Administrative help, clinician contact and a laboratory discount have different roles. A clear explanation of which channel handles a particular question is more useful than assuming every membership feature provides the same kind of medical care.

Compare visits with visits and medicine with medicine

PlushCare’s positive feature is a plainly described physician-led route with an explicit medication-cost exclusion. The unresolved total belongs to the individual plan, not to the $129 headline. Its public listing cannot guarantee prescription availability or coverage for a reader.

The Henry review follows a bundled monthly description, while the Wegovy review is about a branded medicine rather than a clinic. The clinical-conversation guide and treatment guide help keep those different purchases and responsibilities intelligible.

Compare another model

FuturHealth · ReflexMD · G-Plans · Fridays

The invoice guide and product-status guide explain the distinctions behind these entries.

Research record

Documents used

Official public information reviewed October 1, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.

  1. PlushCare: Official program and offer information ↗
  2. FDA: Concerns with unapproved GLP-1 drugs ↗
One more offer to explore

A clearly stated monthly price.

CoreAge Rx advertises compounded treatment with medication, supplies, and shipping together.

Semaglutide$99/month
Tirzepatide$149/month

No separate membership fee advertised.

Explore the CoreAge Rx plans ↗Open the full review →

A prescription and medical eligibility are required. Compounded medicines are not FDA-approved. Confirm the current offer and agreement with the provider.